Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1983]
News [3209]
Articles [134]
Editorials [3]
Conferences [121]
elearning [18]
Minimised BEACOPP exposure and toxicity for Hodgkin lymphoma gives good results
Dr Olivier Casasnovas - CHU de Dijon, Dijon, France
Minimised BEACOPP exposure and toxicity for Hodgkin lymphoma gives good results ( Dr Olivier Casasnovas - CHU de Dijon, Dijon, France )
15 Jun 2018
Subcutaneous daratumumab shows benefit in patients with relapsed or refractory...
Dr Ajai Chari - Mount Sinai Hospital, New York, USA
Subcutaneous daratumumab shows benefit in patients with relapsed or refractory multiple myeloma ( Dr Ajai Chari - Mount Sinai Hospital, New York, USA )
4 Jun 2018
Daratumumab in combination with carfilzomib and dexamethasone for relapsed...
Dr Ajai Chari - Mount Sinai Hospital, New York, USA
Daratumumab in combination with carfilzomib and dexamethasone for relapsed multiple myeloma ( Dr Ajai Chari - Mount Sinai Hospital, New York, USA )
4 Jun 2018
OPTIMISMM trial for refractory multiple myeloma
Dr Paul Richardson - Dana Farber Cancer Institue, Boston, USA
OPTIMISMM trial for refractory multiple myeloma ( Dr Paul Richardson - Dana Farber Cancer Institue, Boston, USA )
3 Jun 2018
Treatment updates in Merkel cell carcinoma
Dr Paul Nghiem - University of Washington, Seattle, USA
Treatment updates in Merkel cell carcinoma ( Dr Paul Nghiem - University of Washington, Seattle, USA )
3 Jun 2018
Nelarabine in newly diagnosed paediatric T-cell malignancies
Dr Kimberly Dunsmore - University of Virginia School of Medicine, Virginia, USA
Nelarabine in newly diagnosed paediatric T-cell malignancies ( Dr Kimberly Dunsmore - University of Virginia School of Medicine, Virginia, USA )
2 Jun 2018
The CAPTIVATE trial of ibrutinib and venetoclax as a first line treatment for...
Prof William Wierda - MD Anderson Cancer Center, Houston, USA
The CAPTIVATE trial of ibrutinib and venetoclax as a first line treatment for CLL patients ( Prof William Wierda - MD Anderson Cancer Center, Houston, USA )
2 Jun 2018
The 2018 Myeloma Knowledge Exchange
Prof Heinz Ludwig - Wilhelminenspital, Center for Oncology and Hematology...
The 2018 Myeloma Knowledge Exchange ( Prof Heinz Ludwig - Wilhelminenspital, Center for Oncology and Hematology, Vienna, Austria )
4 May 2018
Clinical management of plasma cell leukaemia
Dr Francesca Gay - University of Torino, Torino, Italy
Clinical management of plasma cell leukaemia ( Dr Francesca Gay - University of Torino, Torino, Italy )
2 May 2018
Palliative care in multiple myeloma from a nurse's perspective
Erik Aerts - President of HNHCP, Winterthur, Switzerland
Palliative care in multiple myeloma from a nurse's perspective ( Erik Aerts - President of HNHCP, Winterthur, Switzerland )
2 May 2018
Thrombosis risk and management in multiple myeloma
Dr Joseph Mikhael - Chief Medical Officer of the International Myeloma...
Thrombosis risk and management in multiple myeloma ( Dr Joseph Mikhael - Chief Medical Officer of the International Myeloma Foundation )
2 May 2018
Diagnosis and management of smouldering myeloma
Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain
Diagnosis and management of smouldering myeloma ( Prof Maria-Victoria Mateos - University Hospital of Salamanca, Salamanca, Spain )
2 May 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation